Skip to main content
. 2025 Feb 18;52:101242. doi: 10.1016/j.lanepe.2025.101242

Table 1.

Maternal, neonatal and units’ characteristics according to exposure and duration of exposure to opioids with/without midazolam, among survivors at five years.

Unexposed (n = 1952) Exposed
p value
≤7 days (n = 762) >7 days (n = 403)
Maternal characteristics at birth
 Maternal age
 <25 years 368/1952 (18.8) 147/762 (19.5) 70/403 (17.3) 0.61
 25–34 years 1157/1952 (59.3) 460/762 (60.1) 235/403 (58.3)
 ≥35 years 427/1952 (21.9) 155/762 (20.4) 98/403 (24.4)
 Birth in France 1496/1927 (77.7) 571/754 (75.6) 283/401 (70.6) 0.011
 Parents’ socio-economic statusa
 Executive 364/1843 (19.9) 181/729 (24.7) 87/376 (23.0) 0.33
 Intermediate 390/1843 (21.2) 145/729 (20.0) 69/376 (18.3)
 Administration 515/1843 (28.0) 189/729 (26.1) 103/376 (28.2)
 Service, trade 271/1843 (14.5) 101/729 (13.8) 56/376 (14.7)
 Worker, unemployed 303/1843 (16.4) 113/729 (15.4) 61/376 (15.7)
 Multiple pregnancy 628/1952 (32.3) 249/762 (32.6) 135/403 (33.0) 0.97
 Cause of preterm birth
 Preterm labour 747/1952 (38.1) 311/762 (40.1) 159/403 (37.6) 0.41
 Preterm premature rupture of membranes 490/1952 (24.8) 157/762 (20.1) 100/403 (24.6)
 Hypertensive disorders or placenta abruption 441/1952 (22.9) 185/762 (25.0) 89/403 (23.4)
 Isolated foetal growth restriction 126/1952 (6.6) 44/762 (6.0) 22/403 (6.2)
 Other 148/1952 (7.6) 65/762 (8.7) 33/403 (8.2)
 Antenatal corticosteroids 1633/1915 (85.3) 626/748 (83.5) 334/399 (84.3) 0.49
 Magnesium sulphate administration 153/1923 (8.0) 70/749 (9.4) 44/397 (11.6) 0.061
Neonatal characteristics
 Gestational age (weeks)
 24 8/1952 (0.3) 10/762 (1) 34/403 (7.4) <0.001
 25 41/1952 (1.6) 47/762 (4.8) 86/403 (18.6)
 26 98/1952 (3.8) 74/762 (7.5) 113/403 (24.5)
 27 148/1952 (7.7) 92/762 (12.6) 70/403 (20.4)
 28 233/1952 (12.2) 120/762 (16.5) 39/403 (11.4)
 29 311/1952 (16.2) 133/762 (18.3) 25/403 (7.3)
 30 466/1952 (24.3) 143/762 (19.6) 18/403 (5.2)
 31 647/1952 (33.8) 143/762 (19.6) 18/403 (5.2)
 Sex, male 986/1952 (50.6) 399/762 (52.5) 213/403 (53.0) 0.52
 Small-for-GAb 701/1952 (36.3) 244/762 (32.8) 150/403 (39.5) 0.063
 Apgar at 5 min < 7 221/1873 (11.7) 159/728 (21.7) 106/357 (29.1) <0.001
 Neonatal morbidities, at least one 399/1868 (20.7) 255/723 (33.7) 292/386 (74.9) <0.001
 Severe cerebral abnormalities 62/1924 (3.2) 52/753 (6.7) 49/402 (12.1) <0.001
 Necrotizing enterocolitis 35/1932 (1.8) 31/752 (4.0) 43/402 (11.4) <0.001
 median [IQR] age necrotizing enterocolitis 21 [12–32] 28 [21–37] 23 [17–45]
 Severe bronchopulmonary dysplasia 61/1914 (3.0) 42/735 (5.3) 135/381 (35.0) <0.001
 Severe retinopathy of prematurity 6/1936 (0.3) 4/756 (0.4) 29/400 (6.5) <0.001
 Late onset sepsis 288/1938 (14.4) 182/750 (23.0) 191/390 (47.6) <0.001
 Median [IQR] age late onset sepsis 12 [8–19] 14 [10–23] 12 [8–23]
Units’ characteristics
 Birth in level 3c 1697/1952 (86.8) 645/762 (84.4) 353/403 (87.9) 0.44
 Neonatal unit volume activityd
 <55 768/1952 (39.5) 249/762 (33.0) 121/403 (30.2) <0.001
 [55–70] 399/1952 (20.4) 164/762 (21.8) 114/403 (28.4)
 [70–90] 305/1952 (15.8) 144/762 (18.5) 70/403 (17.9)
 ≥90 480/1952 (24.3) 205/762 (26.7) 98/403 (23.5)

Data are No./total (%), unless otherwise indicated. Denominators vary according to the number of missing data for each variable. Percentages are weighted to consider the differences in survey design between gestational age groups, resulting in numbers different from No./total calculation.

GA = gestational age.

a

Defined as the highest occupational status between occupations of the mother and the father, or mother only if living alone.

b

Small-for-GA was defined as birth weight less than the 10th percentile for GA and sex based on French intrauterine “EPOPé” growth curves.22

c

Maternity wards were classified as level 3 when associated with a neonatal intensive care unit (NICU).

d

Number of neonates born before 32 GA admitted in 2011, obtained from the national hospital discharge database.